Top Buy
| Security ▼ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| ProQR Therapeutics N.V. | 12 | 0 | 0 | 0 | €1.76 | €5.61 | 218.423% |
| Phibro Animal Health Corp. A | 7 | 2 | 1 | 0 | €35.20 | €23.16 | -34.211% |
| Pfizer Inc. | 16 | 2 | 3 | 0 | €22.35 | €28.98 | 29.652% |
| Personalis Inc | 20 | 0 | 3 | 0 | €9.01 | €10.39 | 15.336% |
| Penumbra Inc | 1 | 0 | 0 | 0 | €252.40 | - | - |
| Pacira Pharmaceuticals | 10 | 0 | 3 | 0 | €20.20 | €29.38 | 45.441% |
| Pacific Biosciences of California Inc. | 3 | 1 | 1 | 0 | €2.06 | €2.38 | 15.741% |
| Orthofix Medical Inc. | 5 | 0 | 0 | 0 | €13.40 | €14.65 | 9.346% |
| Omnicell Inc. | 8 | 0 | 0 | 0 | €34.40 | €35.26 | 2.500% |
| Omeros Corp. | 19 | 0 | 2 | 0 | €9.37 | €31.39 | 234.988% |
| Ocular Therapeutix Inc. | 18 | 1 | 1 | 1 | €10.67 | €15.58 | 45.974% |
| Novartis AG ADR | 6 | 2 | 1 | 0 | €114.00 | €135.30 | 18.687% |
| Neurocrine Bioscience | 49 | 0 | 2 | 0 | €133.55 | €148.09 | 10.889% |
| Neogen Corp. | 4 | 0 | 0 | 0 | €5.15 | €11.85 | 130.037% |
| Nektar Therapeutics | 14 | 2 | 1 | 1 | €0.58 | €6.37 | 992.790% |
| Natural Alternat. | 9 | 0 | 0 | 0 | €2.94 | - | - |
| Nanobiotix | 3 | 0 | 1 | 0 | €18.30 | - | - |
| Myriad Genetics | 9 | 2 | 2 | 0 | €6.15 | €10.57 | 71.829% |
| MPH Health Care AG | 2 | 0 | 0 | 0 | €24.40 | - | - |
| Merit Medical Systems | 31 | 0 | 2 | 0 | €71.00 | €95.59 | 34.635% |
| Merck KGaA | 4 | 0 | 0 | 0 | €121.00 | €142.50 | 17.769% |
| Merck & Co. Inc. | 11 | 0 | 3 | 0 | €85.70 | €110.41 | 28.833% |
| Medtronic plc | 24 | 1 | 7 | 0 | €87.04 | €89.07 | 2.334% |
| Medpace Holdings Inc | 5 | 5 | 1 | 0 | €470.60 | €416.12 | -11.577% |
| Mednax Inc | 4 | 0 | 1 | 0 | €19.80 | €17.39 | -12.169% |